Higher Plasma Levels of Valerate Produced by Gut Microbiota May Have a Beneficial Impact on Renal Function
Artikel i vetenskaplig tidskrift, 2023

Objective: Observational studies have evaluated the relationships among plasma short chain fatty acids (SCFA) produced by gut microbiota, renal function, and risk of chronic kidney disease (CKD). In the present study, Mendelian Randomization (MR) analysis was applied to obtain unconfounded estimates of the casual association of genetically determined plasma valerate (an SCFA) with kidney function and risk of CKD. Method: MR was performed by using summary-level data from the largest genome-wide association studies (GWAS) conducted on plasma valerate, CKD, and estimated glomerular filtration rate (eGFR; separately in diabetic and nondiabetic individuals). Inverse variance weighted method (IVW), weighted median–based method, MR-Egger, as well as MR-Pleiotropy RESidual Sum and Outlier (PRESSO) were applied. Sensitivity analysis was conducted using the leave-one-out method. Results: No significant association was observed between plasma valerate and CKD (IVW: β = 0.234, p = 0.744). In contrast, plasma valerate was positively associated with eGFR in the total population (IVW: β = 0.049, p = 0.022) and among nondiabetic individuals (IVW: β = 0.058, p = 0.009), but not in the diabetic population (IVW: β = −0.052, p = 0.603). None of the estimated associations was subjected to significant level of heterogeneity. Furthermore, MR-PRESSO analysis did not show any chance of outlier for all estimates. The pleiotropy test, with very a negligible intercept and insignificant p value, also indicated no chance of pleiotropy for all of our estimations (all p > 0.539). The results of the MR-Robust Adjusted Profile Score were identical with the IVW estimates, highlighting again no possibility of pleiotropy. Results of the leave-one-out method demonstrated that the links were not driven by single-nucleotide polymorphisms. Conclusions: Individuals with higher plasma valerate levels had better renal function, defined by eGFR. This finding was observed in the total population and in nondiabetic subjects, but not in those with diabetes. Further research is needed to elucidate the links among plasma valerate, kidney function, and CKD.

Mendelian randomization

glomerular filtration rate

valerate

short chain fatty acids

chronic kidney disease

gut microbiota

Författare

Mohsen Mazidi

Chalmers, Life sciences, Livsmedelsvetenskap

Niki Katsiki

University General Hospital of Thessaloniki "AHEPA"

Maciej Banach

Instytut Centrum Zdrowia Matki Polki

Uniwersytet Zielonogorski

Medical University of Lodz

Journal of the American Nutrition Association

27697061 (ISSN) 2769707X (eISSN)

Vol. In Press

Ämneskategorier

Endokrinologi och diabetes

Miljömedicin och yrkesmedicin

Näringslära

DOI

10.1080/07315724.2019.1664955

PubMed

36786830

Mer information

Senast uppdaterat

2023-03-03